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Abstract
Background: This study determined the diagnostic performance of  new biomarkers for a composite diagnosis of  non-commu-
nicable diseases (NCDs) among Central Africans. 
Methods:  This case-control study was conducted at LOMO Medical Centre, Kinshasa, DR Congo (DRC) between January 
– December, 2008. The cases comprised 226 participants with concurrent presence of  at least 2 or more of  NCDs. Anthropo-
metric parameters and blood pressure were measured while blood samples were assayed for biomarkers. The receiver operating 
characteristics curve and the logistic regression model were applied.
Results: Serum selenium (Se) had specificity and sensitivity of  72.4% and 91.1%, respectively with an area under the curve 
(AUC) of  0.802; Nitric oxide (NO) (specificity: 72.4%; sensitivity: 93.0%) (AUC = 0.800); Thyroid stimulating hormone (TSH) 
levels > 6 Mu/L (specificity: 75%; sensitivity: 65%) (AUC = 0.0.727); serum calcium levels of  ≥ 110g/L (specificity: 76%; sensi-
tivity: 75%) (AUC = 0.822); and daily salt intake of  ≥10 g/day (specificity: 75%; sensitivity: 67%) (AUC = 0.653) in the diagnosis 
of  all NCDs, which were all highly significant (<0.0001).  
Conclusion: Serum Se, NO, calcium, TSH and daily salt intake had high diagnostic performance as biomarkers for identification 
of  patients with concurrent NCDs in the study population. 
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Worldwide, there is a shift from disease patterns asso-
ciated with infections and nutritional deficiency towards 
non-communicable diseases. This new pattern of  diseas-
es is associated with economic development and aging 
populations, but is made worse by rapid rural to urban 
migration and globalization.1,2 This change is rapidly 
spreading throughout sub-Saharan Africa and is partial-
ly mediated by the nutritional transition characterised by 
consumption of  higher calorie food stuffs and a more 
sedentary lifestyle following rural to urban migration. 
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Furthermore, adoption of  behaviours such as smoking 
and excessive alcohol consumption in addition to changes 
in dietary habits due to globalisation are associated with 
an increased incidence of  non-communicable diseases.1,2 
The emergent NCDs have shared risk factors, which may 
suggest a common patho-physiological pathway, paving 
the way for screening of  several sub-clinical NCDs using 
one biomarker.2,3 
Biomarkers with high sensitivity and specificity are 
not only useful in screening the general population for 
sub-clinical diseases which require further diagnostic 
tests, but can be of  great value in predicting the prognosis 
in those diagnosed with clinical and subclinical diseases.4,5 
However, information about diagnostic biomarkers for 
screening non-communicable diseases in Kinshasa, Dem-
ocratic Republic of  Congo (DRC) is lacking. The study 
aimed to determine the diagnostic performance of  var-
ious biomarkers for a composite diagnosis of  all NCDs 
(the presence of  2 or more of  the following clinical con-
ditions: Type 2 diabetes, stroke, myocardial infarction, hy-
pertension, and cancer) among participants in Kinshasa 
Province, Democratic Republic of  Congo.
Methods 
Study design and participants
We conducted a case - control study involving 226 cases 
and 226 controls (1 Case: 1 Control) from January to De-
cember 2008 at LOMO Medical Centre, Kinshasa, DR 
Congo (DRC). The cases were participants with concur-
rent presence of  at least 2 or more of; type 2 diabetes 
mellitus (T2DM), stroke, myocardial infarction, hyperten-
sion, and cancers at defining NCDs without tobacco use 
or excessive alcohol intake by participants. The controls 
were selected out of  2260 apparently healthy individu-
als visiting their parents and friends as in-patients during 
the study period and at the study setting. A random sam-
ple of  10% (n = 226) was selected as eligible controls 
matched to cases for sex, age, ethnicity, post – rural – 
urban migration, and residence in Kinshasa province for 
at least five years. However, 174 controls (response rate 
= 77%) effectively participated in the study without the 
fore mentioned diagnoses, tobacco use, excessive alcohol 
intake, pregnancy, and lactation. 
Ethical consideration
The Ethics Committee, School of  Public Health (Uni-
versity of  Kinshasa), granted the approval for this study. 
Administrative permission was also obtained from the 
Head of  Department of  Clinical Biology. Each partici-
pant signed a written, informed consent after receiving 
detailed information on the purpose of  the study.
Study procedure
Eligible participants were examined after fasting for at 
least 8 hours and disclosure identity in terms of  sex and 
age, and amount of  salt intake daily. Trained nurses mea-
sured height, weight, waist circumference (WC), systolic 
blood pressure (SBP), and diastolic blood pressure (DBP) 
according to standardized protocols. Certified sonogra-
pher (BLM) examined the carotid artery B – mode ultra-
sound imaging using a Biosound Phase (Biosound Inc, 
Indianopolis, USA), a device equipped with a annular ar-
ray probe of  7.5 Mhz. Carotid Intima – media thickness 
(cIMT) was measured at near and far wall interfaces of  
internal and external carotid arteries.
Blood (total, serum and plasma) samples were assayed 
immediately to measure concentrations of  erythrocyte 
sedimentation (ESR), haemoglobin, CD4 count, high 
density cholesterol (HDL), total cholesterol, triglycerides, 
low density lipoprotein (LDL), oxidized low density lipo-
protein (oxLDL), cortisol, C – peptide, glucose, C – re-
active protein (CRP), insulin, calcium, D – dimer, nitrous 
oxide (NO), thyroid stimulating hormone (TSH), and im-
munoglobulin G (IgG) against Helicobacter pylori(Hp). Ho-
meostasis – insulin resistance index (HOMA – IR) was 
calculated using fasting glucose and insulin. 
Laboratory data were obtained using calibrated and 
standard routine procedures and specific protocols of  
manufacturers’ suchmetric Sensor as  CyFlowR Counter 
(Partec GmH, Munster, Germany), Hydrasys system (Ser-
bia, Evry, France), spectrophotomer Hospital Diagnos-
tics (Florence, Italy), kits of  Biome’rieux (Marcy l’Etoile, 
France) and Mercodia AB (Silveniusgatan 8 A, SE754, 
Uppsala, Sweden, and a caloric Sensor Hach DR/2010 
spectophotomer (HACH, USA). The Hach DR/2010 
was ideal for both field and mobile laboratory use since 
it is portable, operating from either battery or line power. 
An Orion model 801 microprocessor ionalyzer was used 
to lead SIE testing.
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Definitions
The physical data were structural markers such as WC 
and cIMT for metabolic syndrome (MS) and atheroscle-
rosis, respectively. Laboratory data were biomarkers to 
define the following diseases and syndromes (constella-
tion or clusters): ESR and IgG against Hp for infections, 
insulin resistance, MS, and atherosclerosis; haemoglobin 
for nutritional status, sickle cell disease, anaemia, endem-
ic infections, heart failure, and chronic kidney disease; 
CD4 for immunity; triglycerides, total cholesterol, HDL, 
LDL, glucose, C – peptide, uric acid, and HOMA – IR 
for dyslipidemia, hypertension, diabetes mellitus, MS, in-
sulin resistance, and atherosclerosis; NO for endothelial 
dysfunction; D – dimer for MS and hypercoagulability; 
CRP for inflammation, infections, and cytokines; Se defi-
ciency key trace element in nutrition and oxLDL for ox-
idative stress imbalance and atherosclerosis; Cortisol for 
distress hormone; TSH for iodine nutrition and thyroid 
hormones; and calcium for cancers, atherosclerosis, and 
vitamin D. Electrocardiograms, X–ray features, enzymes, 
coronary angiograms, ultrasound and histological studies 
confirmed the presence and absence of  NCDs. 
Statistical analysis
For univariate descriptive statistics, data were presented 
as count (frequency = number =n) and proportions (%) 
for categorical variables and means ± standard deviations 
(SD) for continuous variables normally distributed. The 
diagnostic performance cut-off  values of  various bio-
markers at discriminating NCDs and controls were test-
ed a posteriori, using the receiver operating characteristic 
curve (ROC) method. The areas under the curve (AUC 
for c- static) were calculated with the corresponding Stan-
dard Error and 95% CI (Figure 1-2). Multivariate analysis 
was applied to establish the independent predictors of  
NCDs that could potentially be used to identify individ-
uals at high risk of  developing incident NCDs. A p-value 
of  <0.05 was considered as statistically significant. All 
statistical analyses were performed using Statistical Pack-









Figure 2. ROC curves showing the sensitivity and specificity of various diagnostic biomarkers for all NCDs 
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Figure 2. ROC curves showing the sensitivity and specificity of various diagnostic biomarkers for all NCDs 
Results
Participants’ mean age was 65.6 ± 11.5 years (range 27 – 
84). The cases comprised of  116 males and 110 females 
(mean age 64.8 ± 11.7 years), while controls were 84 males 
and 90 females (mean age 66.6 ± 11.2 years). Shown in 
Table 1 are the biomarkers’ definition of  NCDs. Apart 
from ESR (p=0.961) and salt intake (p=0.077), all others 
biomarkers were highly significant between the cases and 
the controls. 
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(Mean ± SD) 
  
Controls 







HDL-C (mg/dL) 24.86 ± 2.066 50.67 ± 2.82 56.924 <0.0001 
LDL-C (mg/dL) 128.15 ± 2.89 98.21 ± 3.03 49.919 <0.0001 
Triglycerides (mg/dL) 147.73 ± 2.89 109.94 ± 4.30 36.909 <0.0001 
Waist circumference (cm) 84.30 ± 0.87 74.06 ± 0.53 87.678 <0.0001 
SPB (mmHg) 137.77 ± 2.25 116.64 ± 0.70 63.946 <0.0001 
DBP (mmHg) 77.07 ± 0.98 68.99 ± 0.80 36.477 <0.0001 
Total cholesterol (mg/dL) 166.96 ± 4.25 140.93 ± 4.81 16.405 <0.0001 
Uric acid (mg/dL) 6.20 ± 0.20 4.73 ± 0.13 32.801 <0.0001 
Fasting plasma glucose (mg/dl) 198.54 ± 8.66 94.98 ± 1.16 108.882 <0.0001 
Selenium (µg/L) 17.95 ± 0.91 78.40 ± 4.33 325.357 <0.0001 
ESR (mm/1st Hour) 51.89 ± 1.67 52.02 ± 2.0 0.002 0.961 
Nitric oxide (µmol/dL)  5.23 ± 0.46 25.89 ± 1.37 248.293 <0.0001 
IgG anti-Helicobacter pylori 100.8 ± 4.97 75.11 ± 4.40 13.278 <0.0001 
Oxidised LDL (iU/L) 176.29 ± 4.90 80.78 ± 6.40 145.929 <0.0001 
CD4 count (Cells/ µL) 396.23 ± 10.83 908.05 ± 29.00 327.514 <0.0001 
D-dimer (ng/mL) 2119.41 ± 152.97 491.51 ± 27.03 85.554 <0.0001 
CRP (mg/dL) 4.7 ± 1.24 2.1 ± 0.9 2.41± 1.3 <0.0001 
cIMT (mm) 0.685 ± 0.025 0.487 ± 0.024 31.588 <0.0001 
Serum calcium (mg/L) 140.01 ± 3.07 89.90 ± 1.84 168.871 <0.0001 
Salt intake (g/Day) 13.39 ± 0.433 12.00 ± 0.70 3.134 0.077 
Haemoglobin (mg/Dl) 10.50 ± 2.43 12.01 ± 2.94 31.976 <0.0001 
Cortisol 23.39 ± 0.76 19.55 ± 0.80 11.765 <0.0001 
Fasting C-peptide (µg/L) 2.61 ± 0.13 1.37 ± 0.03 67.204 <0.0001 
HOMA-IR Index  12.62 ± 0.76 8.19 ± 0.50 136.939 <0.0001 
TSH (miU/L) 4.30 ± 0.12 2.40 ± 0.19 76.569 <0.0001 
ESR=Erythrocytesedimentation; HDL-C=High density lipoprotein cholesterol; LDL-C=low density lipoprotein; 
oxLDL=Oxidized low density lipoprotein; CRP=C – reactive protein; NO=Nitrous oxide; TSH=Thyroid stimulating 
hormone; IgG=Immunoglobulin G; Hp=Helicobacter pylori; HOMA-IR= Homeostasis – insulin resistance index; 
cIMT=Carotid Intima – media thickness  
Shown in Table 2 is the area under the curve for vari-
ous diagnostic markers of  all NCDs, while the sensitivity 
and specificity of  various diagnostic biomarkers for all 
NCDs is presented in Table 3. Serum selenium had spec-
ificity and sensitivity of  72.4% and 91.1%, with an area 
under the curve (AUC) of  0.802; Nitric oxide (specifici-
ty: 72.4%; sensitivity: 93.0%) (AUC = 0.800); TSH levels 
> 6 Mu/L (specificity: 75%; sensitivity: 65%) (AUC = 
0.0.727); serum calcium levels of  ≥ 110g/L (specifici-
ty: 76%; sensitivity: 75%) (AUC = 0.822); and daily salt 
intake of  ≥10 g/day (specificity: 75%; sensitivity: 67%) 
(AUC = 0.653) in the diagnosis of  all NCDs, which were 
all highly significant (<0.0001).  
Table 2:  Sensitivity and specificity of various diagnostic biomarkers for all NCDs 
 
Biomarkers Cut off limit Sensitivity Specificity 
Serum selenium (mg/dL <35 72.4% 91.1% 
Nitric oxide (µmol/dL) <10 72.4% 93.0% 
cIMT (mm) >0.50 60.0% 61.0% 
Serum calcium (mg/dL) >110  76.1% 75.0% 
Salt intake (g/day) >10  75.0% 67.0 % 
TSH (mU/mL) >6 74.8% 65.0% 
CD4 (cells/mL) <500  76.4% 85.0% 
cIMT=Carotid Intima – media thickness; TSH=Thyroid stimulating hormone 
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Table 3: Area under the curve for various diagnostic markers of all NCDs 
 
Biomarkers AUC SE 95% CI p-value 
CD4 (cells/mL) 0.900 0.015 0.871 – 0.930 <0.0001 
Serum calcium (mg/dL 0.822 0.020 0.793 – 0.872 <0.0001 
Serum selenium (mg/dL 0.802 0.021 0.800 – 0.833 <0.0001 
Nitric oxide (µmol/dL) 0.800 0.025 0.750 – 0.849 <0.0001 
TSH (mU/mL) 0.727 0.028 0.672 – 0.781 <0.0001 
Salt intake (g/day) 0.661 0.030 0.601 – 0.721 <0.0001 
cIMT (mm) 0.653 0.028 0.599 -  0.707 <0.0001 
TSH=Thyroid stimulating hormone; cIMT=Carotid Intima – media thickness 
Discussion
In the current study, serum selenium ≤ 35µg/L had spec-
ificity and sensitivity of  72.4% and 91.1%, respectively, 
for identifying cases of  NCDs. Se deficiency alone rare-
ly leads to clinical manifestation, but in association with 
other factors, exacerbates disease manifestation.6,7 Nor-
mal physiological reactions usually generate oxygen and 
nitrogen reactive species which are quickly neutralised by 
endogenous anti-oxidants such as the selenium depen-
dent glutathione.8 The most basic oxidant molecules are 
superoxide and its metabolite hydrogen peroxide (H2O2), 
which are produced from 1-4% of  the inspired oxygen by 
the normal physiological activities of  energy producing 
mitochondria, metabolic function of  the endoplasmic re-
ticulum, and defensive/ inflammatory role of  lysosomes 
and other cellular organelles13. In selenium deficiency, 
there is diminished glutathione peroxidase anti-oxidant 
capacity, accumulation of  superoxide and hydrogen per-
oxide and lipid peroxides with resultant oxidative dam-
age to structural proteins and lipids, enzymatic and repair 
proteins, signalling molecules and DNA predisposing to 
progressive multi-organ damage, increased risk of  chron-
ic degenerative diseases and malignancy.8,9 
The present study indicates that NO is one of  the bio-
markers with high diagnostic performance for all NCDs 
among the study population with an area under the curve 
of  0.800, and sensitivity and specificity of  72.4% and 
93.0%, respectively. Nitric oxide is an endogenous me-
diator of  several physiological processes which include 
vasorelaxation, macrophage activation, gene expression 
and apoptosis and it is one of  the most prominent vas-
culo-protective molecules.9 In the presence of  increased 
superoxide concentration, nitric oxide is quickly oxidised 
to the more potent oxidant stress molecule peroxynitrite 
(ONOO-) which is associated with endothelial dysfunc-
tion and activation; increased intima-media thickness, an 
early marker of  atherosclerosis and cardiovascular dis-
ease; nitrosylation of  proteins and oxidative damage to 
DNA and cell cycle regulator proteins.10 
The findings of  this present study indicate that TSH lev-
els  > 6 Mu/L had a specificity and sensitivity of  75% and 
65% respectively, in diagnosing all NCDs. TSH was sig-
nificantly higher among cases of  NCDs than controls de-
spite no difference in mean T3 and T4 (data not shown) 
suggesting subclinical hypothyroidism among cases. With 
nearly 2 billion people having inadequate iodine in their 
diet globally,11 iodine deficiency is likely to be the main 
cause of  hypothyroidism and may be the main underly-
ing cause in the study population given endemic iodine 
deficiency in DRC.12 A significant proportion of  the pop-
ulation in DRC, with inadequate iodine supplementation 
and concurrent consumption of  goitregenic diet, may 
be prone to sub-clinical hypothyroidism and chronical-
ly elevated TSH. TSH activity in the thyroid gland leads 
to NADPH oxidation by NADPH oxidase producing 
NADP and superoxide radicals. The superoxide radicals 
are then converted to the less potent H2O2, by superoxide 
dismutase, a selenium-dependent enzyme. H2O2 that is 
not used up in this process is neutralized by selenium-de-
pendent glutathione peroxidase.13 Also, the reduced bio-
availability of  NO results in chronic elevation of  TSH. 
This in turn,  leads to increased circulating levels of  
LDC-C and thus, reduced function of  hepatic LDL re-
ceptors. Chronic inflammation is then mediated by higher 
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circulating levels of  TNF α and IL-6.14-16 This results in 
reduced endothelial mediated vasodilation and increased 
intima-media thickness in the systemic circulation, an ear-
ly marker of  atherosclerosis and therefore, a herald of  
multiple organ failure.17 Elevated TSH is a risk factor for 
increased cardiovascular disease mortality among men < 
50 years and women >60.18,19 Iodine deficiency is not only 
one of  the leading causes of  hypothyroidism15, but it also 
accounts for marked reduction in exogenous anti-oxidant 
capacity as iodine is three times a more potent anti-oxi-
dant than Vitamin C and is concentrated in several body 
organs such as the eye, thyroid, prostate, breast and gut, 
where it may have a crucial protective effect against oxi-
dant molecules.20 
In this current study, serum calcium levels ≥ 110g/L had 
a sensitivity and specificity of  76% and 75% in the diag-
nosis of  all NCDs. Therefore, in the absence of  elevated 
PTH, underlying malignancy should be ruled out in all 
individuals presenting with hypercalcaemia. Although hy-
percalcaemia did not feature as an independent determi-
nant of  NCDs, it features as an important biomarker with 
high sensitivity and specificity for diagnosis of  all NCDs. 
Primary hyperparathyroidism and malignancy account 
for about 90% of  all cases of  hypercalcaemia making 
malignancy the second highest cause of  hypercalcemia in 
adults.21 Although hypercalcaemia is one of  the earliest 
manifestation of  malignancy, it is usually asymptomatic 
until serum levels are ≥ 120g/L. It is an early marker of  
several underlying malignancies, particularly, squamous 
cell carcinoma of  the lung, lymphomas. This is due to 
humoral hypercalcemia of  malignancy, mainly caused by 
overproduction of  PTH related protein (PTHrP) espe-
cially prevalent in lung cancer, cancers of  the head and 
neck, skin, esophagus, breast, genitourinary tract, multi-
ple myeloma, and lymphoma.21,22 
The finding of  this present study indicates that a daily 
salt intake of  ≥10 g/day had 75% and 67% sensitivity 
and specificity, respectively, as a diagnostic marker for all 
NCD. Additionally, both cases and controls had compara-
ble average daily salt intake, which is more than twice the 
recommended average of  6 g/day (13.39 ± 0.433 g/day 
for cases and 12.00 ± 0.70 for controls (p = 0.077).23,24 A 
high salt intake is a risk factor for hypertension, cardio-
vascular disease and kidney injury.25
Conclusion 
Serum Se, NO, Calcium, TSH, CD4+ count, cIMT and 
daily salt intake had high diagnostic performance as bio-
markers for identification of  patients with concurrent 
NCDs in the study population. This provides an oppor-
tunity for integrated screening for all NCDs using one or 
a combination of  a few of  these biomarkers. 
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